Skip to content

Addiction: all studies

Page 737 of 857: studies 7,361 to 7,370 of 8,563, newest first. Back to the addiction overview

Research

The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis

Drug and Alcohol Review May 1, 2009 Leanne M Hides, David J. Kavanagh, Sharon Dawe et al.

Abstract: Introduction and Aims. Little is known about motives or expectancies for cannabis use in psychotic populations, despite these cognitive factors being a central focus of the treatment for substance misuse in psychosis. This study examined the relationship between cannabis use expectancies, cannabis use and psychotic symptoms among cannabis using psychotic inpatients. A secondary aim...

The effects of cannabinoids on serum cortisol and prolactin in humans.

Psychopharmacology May 2009 Mohini Ranganathan, Gabriel Braley, Brian Pittman et al.

Cannabis is one of the most widely used illicit substances, and there is growing interest in the therapeutic applications of cannabinoids. While known to modulate neuroendocrine function, the precise acute and chronic dose-related effects of cannabinoids in humans are not well-known. Furthermore, the existing literature on the neuroendocrine effects of cannabinoids is limited by small sample...

In vitro stability and metabolism of salvinorin A in rat plasma.

Xenobiotica May 1, 2009 Kenji Tsujikawa, Kenji Kuwayama, Hajime Miyaguchi et al. 64 citations

Salvinorin A is the main active psychoactive ingredient in Salvia divinorum, a Mexican plant that has been widely available as a hallucinogen in recent years. The aims of this study were to investigate the stability of salvinorin A in rat plasma, esterases responsible for its degradation, and estimation of the degradation products. The apparent first-order rate constants of salvinorin A at 37...

DOI: 10.1080/00498250902769967 (opens in new tab) Full text (opens in new tab) Salvinorin a Potent natural compound This compound Drug metabolism +12

Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.

Molecular Pharmacology April 2009 Alan M Roloff, Stanley A Thayer

Delta(9)-tetrahydrocannabinol (THC), the principal psychoactive ingredient in marijuana, acts as a partial agonist on presynaptic cannabinoid type 1 (CB1) receptors to inhibit neurotransmitter release. Here, we report that THC inhibits excitatory neurotransmission between cultured rat hippocampal neurons in a manner highly sensitive to stimulus rate. THC (1 microM) inhibited excitatory...

Seeing the invisible: the scope and limits of unconscious processing in binocular rivalry.

Progress in Neurobiology April 2009 Zhicheng Lin, Sheng He

When an image is presented to one eye and a very different image is presented to the corresponding location of the other eye, the two images compete for conscious representations, such that only one image is visible at a time while the other is suppressed. Called binocular rivalry, this phenomenon and its deviants have been extensively exploited to study the mechanism and neural correlates of...

Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol

Archives of General Psychiatry April 1, 2009 Sagnik Bhattacharyya, Paolo Fusar‐poli, Stefan Borgwardt et al. 250 citations

CONTEXT: Cannabis sativa use can impair verbal learning, provoke acute psychosis, and increase the risk of schizophrenia. It is unclear where C. sativa acts in the human brain to modulate verbal learning and to induce psychotic symptoms. OBJECTIVES: To investigate the effects of 2 main psychoactive constituents of C. sativa, Delta9-tetrahydrocannabinol (Delta9-THC) and cannabidiol, on regional...

Meditation and Treatment of Female Trauma Survivors

Integrative Body–Mind–Spirit Social Work March 25, 2009 Mo Yee Lee, Siu-Man Ng, Pamela Pui Yu Leung et al.

Abstract: Posttraumatic stress disorder (PTSD) became a formal diagnosis included in DSM-III only in 1980 on account of the organized efforts of Charles Figley, Chaim Shatan, and other advocate groups for veterans and trauma survivors. Trauma has pervasive and devastating impacts on individuals. Trauma survivors, especially those with prolonged histories of interpersonal abuse, typically suffer...

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Journal of Psychopharmacology March 20, 2009 Jörg Daumann, Daniel Wagner, Karsten Heekeren et al. 62 citations

Deficits in attentional functions belong to the core cognitive symptoms in schizophrenic patients. Alertness is a nonselective attention component that refers to a state of general readiness that improves stimulus processing and response initiation. The main goal of the present study was to investigate cerebral correlates of alertness in the human 5HT(2A) agonist and N-methyl-D-aspartic acid...

Developmentally regulated and thalamus-selective induction of leiomodin2 gene by a schizophrenomimetic, phencyclidine, in the rat

The International Journal of Neuropsychopharmacology March 2, 2009 Hironao Takebayashi, Naoki Yamamoto, Asami Umino et al. 17 citations

The onset of schizophrenia and the schizophrenomimetic effects of an N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, rarely occur during infancy and childhood, suggesting that schizophrenia-related neuron circuits and molecules in the brain might show an age-related response to an NMDA receptor antagonist. By using a DNA microarray technique, we have identified the developmentally...

Mindfulness‐based cognitive therapy may reduce thought suppression in previously suicidal participants: Findings from a preliminary study

British Journal of Clinical Psychology March 2, 2009 Silvia R. Hepburn, Catherine Crane, Thorsten Barnhofer et al. 74 citations

OBJECTIVES: Thought suppression is a strategy aimed at mental control that may paradoxically increase the frequency of unwanted thoughts. This preliminary study examined effects of mindfulness-based cognitive therapy (MBCT) on thought suppression and depression in individuals with past depression and suicidality. METHODS: In a randomized controlled trial design, 68 participants were allocated...

DOI: 10.1348/014466509x414970 (opens in new tab) Mindfulness-based cognitive therapy Thought suppression Psychotherapist Cognition +3